Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 5.09B |
| Enterprise Value | 3.04B |
| P/E Ratio | 30.93 |
| PEG Ratio | -0.45 |
| Price/Sales Ratio | 2.47 |
| Price/Book Ratio | 1.31 |
| Enterprise/Revenue | 1.68 |
| Enterprise/EBITDA | 12.05 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.1 |
| Operating Margin | 0.08 |
| Return On Assets | 0.04 |
| Return On Equity | 0.04 |
| Revenue | 2.45B |
| Revenue/Share | 10.76 |
| Gross Profit | 1.69B |
| EBITDA | 418.16M |
| Net Income | 244.51M |
| Diluted EPS | 1.08 |
| Total Cash | 2.4B |
| Total Cash/Share | 10.69 |
| Total Debt | 416.01M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 3.73 |
| Book Value Per Share | 24.83 |
| 52-Week Change | -33.69 |
| 52-Week High | 31.28 |
| 52-Week Low | 15.66 |
| Moving Average 50 Days | 20.08 |
| Moving Average 200 Days | 24.51 |
| Average Volume | 180,818 |
| Shares Outstanding | 401.99M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 3.17 |
| Payout Ratio | 1.33 |
| Last Split Factor | 7:5 |
| Last Split Date | June 06, 2024 |